Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cardiome Pharma Corp (NASDAQ:CRME)

9.00
Delayed Data
As of 3:59pm ET
 -0.02 / -0.22%
Today’s Change
6.51
Today|||52-Week Range
11.31
-2.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues1.5M789.0K4.5M30.0M
 
 
 
 
 
Cost of Goods Sold15.2M--936.0K10.0M
 
 
 
 
Depreciation And Amortization1.1M1.2M649.0K2.2M
 
 
 
 
 
 
Operating ExpensesGross Income-14.8M--2.9M17.9M
 
 
 
 
General Expenses11.5M15.6M16.9M34.5M
 
 
 
 
 
Research And Development--6.0M476.0K637.0K
 
 
 
 
Total Operating Expenses27.9M16.9M18.5M46.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-26.4M-16.1M-14.0M-16.6M
 
 
 
 
 
Extraordinary Credit0.0011.2M20.8M0.00
 
 
 
Extraordinary Charge-95.0K-10.0M-2.7M0.00
 
 
 
 
Interest Expense On Debt2.2M4.3M87.0K1.5M
 
 
 
 
 
Other Expenses756.0K843.0K825.0K-110.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-27.9M-18.3M4.9M-18.2M
 
 
 
 
 
Income Taxes0.000.00-102.0K-49.0K
 
 
 
Net Income-27.9M-18.3M4.8M-18.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.2M12.3M12.8M16.2M
 
 
 
 
 
Shares To Calculate EPS Diluted12.2M12.3M12.9M16.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.30-$1.50$0.37-$1.12
 
 
 
 
 
EPS Diluted-$2.30-$1.50$0.37-$1.12